Friday Feb 28
$500K gift supports after school program at pharmacy college
Drug developer AMRI and company co-founder Tom D'Ambra and his wife Connie have donated a total of $500,000 to support an after school program run by the Albany College of Pharmacy and Health Sciences.
Insider Selling: Steven R. Hagen Sells 3,000 Shares of Albany Molecular Research Stock
Albany Molecular Research SVP Steven R. Hagen sold 3,000 shares of Albany Molecular Research stock in a transaction that occurred on Thursday, February 27th.
Albany Molecular Research Inc. (AMRI) Selects FirstLight Fiber for 10 Gbps Network Upgrade
As a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services, AMRI operates a vast data network connecting multiple locations.
Insider Selling: Steven R. Hagen Unloads 1,500 Shares of Albany Molecular Research Stock
Albany Molecular Research SVP Steven R. Hagen sold 1,500 shares of the company's stock in a transaction dated Friday, February 21st.
Albany Molecular Research Upgraded to Buy by McLean Capital Management
Albany Molecular Research traded up 4.10% on Friday, hitting $14.99. 864,078 shares of the company's stock traded hands.
10 minutes with new AMRI chief Bill Marth
"We may act as a consolidator, buying a series of smaller companies and folding them into what we already have," says Bill Marth, AMRI's new president and CEO William Marth.
AMRI to focus on scale and capabilities of API biz following robust 2013
AMRI says it intends to expand its API business to target both generics and more complex molecules after reporting record full year revenue from contract services.
Insider Selling: Stuart M. Cable Sells 30,000 Shares of Albany Molecular Research Stock
Albany Molecular Research major shareholder Stuart M. Cable sold 30,000 shares of the stock in a transaction that occurred on Thursday, February 13th.
Albany Molecular Research, Inc. (AMRI) Announces Fourth Quarter And...
Key leadership changes include new President and CEO, Senior Vice President of Discovery, Senior Vice President Sales and General Manager API , and Managing Director, AMRI India Adjusted diluted EPS, adjusted EBITDA, and adjusted operating income excluding royalties are non-GAAP measures, which exclude certain items detailed later in this press ... (more)
Albany Molecular Research (AMRI) Posts Quarterly Results
Albany Molecular Research released its earnings data on Wednesday. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.05, American Banking and Market News reports.